[go: up one dir, main page]

HK1220233A1 - 用於神經變性疾病的細胞性發現平台 - Google Patents

用於神經變性疾病的細胞性發現平台

Info

Publication number
HK1220233A1
HK1220233A1 HK16108219.0A HK16108219A HK1220233A1 HK 1220233 A1 HK1220233 A1 HK 1220233A1 HK 16108219 A HK16108219 A HK 16108219A HK 1220233 A1 HK1220233 A1 HK 1220233A1
Authority
HK
Hong Kong
Prior art keywords
neurodegenerative diseases
discovery platform
cellular
cellular discovery
platform
Prior art date
Application number
HK16108219.0A
Other languages
English (en)
Inventor
‧林德奎斯特
‧庫拉納
‧鍾
Original Assignee
Whitehead Inst Biomedical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Inst Biomedical Res filed Critical Whitehead Inst Biomedical Res
Publication of HK1220233A1 publication Critical patent/HK1220233A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16108219.0A 2013-03-15 2016-07-13 用於神經變性疾病的細胞性發現平台 HK1220233A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361794870P 2013-03-15 2013-03-15
US201361857648P 2013-07-23 2013-07-23
US201361895274P 2013-10-24 2013-10-24
PCT/US2014/030838 WO2014145975A2 (en) 2013-03-15 2014-03-17 Cellular discovery platform for neurodegenerative diseases

Publications (1)

Publication Number Publication Date
HK1220233A1 true HK1220233A1 (zh) 2017-04-28

Family

ID=51538585

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16108152.9A HK1220232A1 (zh) 2013-03-15 2016-07-12 用於神經變性疾病的細胞性發現平台
HK16108219.0A HK1220233A1 (zh) 2013-03-15 2016-07-13 用於神經變性疾病的細胞性發現平台

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16108152.9A HK1220232A1 (zh) 2013-03-15 2016-07-12 用於神經變性疾病的細胞性發現平台

Country Status (9)

Country Link
US (1) US11047848B2 (zh)
EP (2) EP3736343A1 (zh)
JP (2) JP7182852B2 (zh)
CN (1) CN105247070A (zh)
BR (1) BR112015023533A2 (zh)
CA (1) CA2906197A1 (zh)
HK (2) HK1220232A1 (zh)
IL (1) IL241310B (zh)
WO (1) WO2014145975A2 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016033501A1 (en) 2014-08-28 2016-03-03 Robert John Petcavich Method of fabricating cell arrays and uses thereof
US11261453B2 (en) 2014-09-12 2022-03-01 Whitehead Institute For Biomedical Research Cells expressing apolipoprotein E and uses thereof
KR101816103B1 (ko) * 2015-04-13 2018-01-08 고려대학교 산학협력단 소분자 화합물을 이용한 인간 섬유아세포를 신경줄기세포로 직접 전환하는 방법
WO2016210313A1 (en) * 2015-06-24 2016-12-29 Whitehead Institute For Biomedical Research Culture medium for generating microglia from pluripotent stem cells and related methods
US11248212B2 (en) 2015-06-30 2022-02-15 StemoniX Inc. Surface energy directed cell self assembly
US10760053B2 (en) 2015-10-15 2020-09-01 StemoniX Inc. Method of manufacturing or differentiating mammalian pluripotent stem cells or progenitor cells using a hollow fiber bioreactor
CN105838691B (zh) * 2016-04-18 2018-07-06 浙江大学 一对转录激活子样效应因子核酸酶及其编码基因与应用
CN106148286B (zh) * 2016-06-29 2019-10-29 牛刚 一种用于检测热原的细胞模型的构建方法和细胞模型及热原检测试剂盒
JP7288853B2 (ja) * 2017-01-25 2023-06-08 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ ゲノムネットワークを構築するための方法およびその使用
US10675328B2 (en) 2017-02-14 2020-06-09 Children's Hospital Medical Center Compositions and methods for treatment of Gcase related disease states
CN106916907A (zh) * 2017-05-04 2017-07-04 张家港蓝苏生物工程有限公司 一种特异性检测单纯疱疹病毒ⅰ、ⅱ型核酸的荧光pcr方法及试剂盒
EP3694536A4 (en) * 2017-10-12 2021-08-18 The Regents of The University of California CELL-BASED SEEDING ASSAY FOR HUNTINGTINE AGGREGATION
CN108913614B (zh) * 2018-07-20 2022-11-04 江南大学 一种调节酿酒酵母氧胁迫的方法
WO2020047043A1 (en) 2018-08-28 2020-03-05 Lenzi Tommaso Variable transmission for assistive prosthesis device
KR102143320B1 (ko) * 2018-08-28 2020-08-12 주식회사 스템랩 합성 메신저 rna를 이용하여 소변세포를 신경줄기세포로 직접 역분화하는 방법
WO2020068731A1 (en) * 2018-09-25 2020-04-02 The General Hospital Corporation Methods for integrating cell gene expression data from multiple single-cell data sets and uses thereof
EP3894578A4 (en) * 2018-12-13 2022-12-14 Ramot at Tel-Aviv University Ltd. INTEGRATED DRUG DISCOVERY PLATFORM FOR INHERITED METABOLIC DISEASES
KR20210124374A (ko) 2019-02-08 2021-10-14 듀포인트 테라퓨틱스, 인크. 화합물의 응축물-연관된 특징을 특징규명하는 방법 및 그의 용도
EP4031876A1 (en) * 2019-09-18 2022-07-27 Dewpoint Therapeutics, Inc. Methods of screening for condensate-associated specificity and uses thereof
CA3154805A1 (en) * 2019-10-18 2021-04-22 Iosif PEDIADITAKIS Brain-chip modeling neurodegeneration and neuroinflammation in parkinson's disease
WO2021158184A1 (en) * 2020-02-07 2021-08-12 Vidyasirimedhi Institute Of Science And Technology Method of producing modified amyloid precursor protein anchored with detectable moieties and modified amyloid peptides derived thereof
WO2021188947A1 (en) 2020-03-20 2021-09-23 University Of Utah Research Foundation Self-aligning mechanisms in passive and powered exoskeletons
WO2022126486A1 (zh) * 2020-12-17 2022-06-23 深圳先进技术研究院 一种工程化神经细胞及其制备方法和应用
WO2024026115A2 (en) * 2022-07-28 2024-02-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Protein aggregation assay and methods of using the same
CN117050945B (zh) * 2023-10-11 2024-01-26 北京市眼科研究所 体外培养类玻璃体的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233061T3 (de) * 1991-07-08 2008-07-10 Neurospheres Holding Ltd., Calgary Auf wachstumsfaktoren reagierende neurale vorläuferzellen, die in vitro vermehrt werden können.
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
EP1259637A2 (en) * 2000-03-02 2002-11-27 McGILL UNIVERSITY Caspase-inhibitory-factor (cif) and uses thereof
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
EP1392849B2 (en) 2001-02-15 2012-01-18 University Of Chicago Yeast screens for agents affecting protein folding
US7432104B2 (en) 2001-08-06 2008-10-07 Bresgen Inc. Methods for the culture of human embryonic stem cells on human feeder cells
US7452670B2 (en) 2003-12-04 2008-11-18 University Of Washington Methods of identifying agents that diminish cellular toxicity associated with an α-synuclein polypeptide of Parkinson's disease in yeast
CA2563087A1 (en) * 2004-04-09 2005-12-15 Ronald S. Goldstein Methods for generating neuronal cells from human embryonic stem cells and uses thereof
NZ588432A (en) 2004-09-17 2012-03-30 Whitehead Biomedical Inst Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
CA2589700A1 (en) 2004-12-01 2006-07-13 Whitehead Institute For Biomedical Research Modulators of alpha-synuclein toxicity
JP2008545628A (ja) 2005-05-13 2008-12-18 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ α−シヌクレイン毒性のモジュレーター
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US20090010894A1 (en) 2005-12-23 2009-01-08 The Parkinson's Institute Methods and systems for identifying compounds that modulate alpha-synuclein aggregation
BRPI0709699A2 (pt) 2006-03-29 2011-07-26 Foldrx Pharmaceuticals Inc inibiÇço da toxidez da alfa-sinucleina
RU2502799C2 (ru) 2007-04-07 2013-12-27 Уайтхед Инститьют Фор Биомедикал Рисёч Способ перепрограммирования соматических клеток
US7861880B2 (en) * 2007-06-28 2011-01-04 Britt Mark W Portable and/or collapsible containers having pliable surfaces
US9102919B2 (en) 2007-08-31 2015-08-11 Whitehead Institute For Biomedical Research WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors
WO2009086306A1 (en) 2007-12-21 2009-07-09 Whitehead Institute For Biomedical Research Modulators of alpha-synuclein toxicity
WO2009102995A1 (en) 2008-02-15 2009-08-20 Whitehead Institute For Biomedical Research Yeast cells expressing tar dna-binding protein 43 and uses therefor
US20100021437A1 (en) 2008-04-07 2010-01-28 The McLean Hospital Corporation Whitehead Institute for Biomedical Research Neural stem cells derived from induced pluripotent stem cells
WO2010042669A2 (en) * 2008-10-07 2010-04-15 Ipierian, Inc. Co-culture compositions and methods
US8865411B2 (en) 2009-03-26 2014-10-21 National Institutes Of Health (Nih) Methods of identifying modulators of TDP-43 mediated cellular toxicity
WO2010117464A1 (en) 2009-04-09 2010-10-14 Sangamo Biosciences, Inc. Targeted integration into stem cells
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
US9677079B2 (en) 2010-01-12 2017-06-13 Whitehead Insititute for Biomedical Research Yeast cells expressing amyloid beta and uses therefor
EP3594333B1 (en) 2010-02-08 2023-11-01 Sangamo Therapeutics, Inc. Engineered cleavage half-domains
CA2796464C (en) 2010-04-16 2021-08-03 Immune Disease Institute, Inc. Sustained polypeptide expression from synthetic, modified rnas and uses thereof
WO2011142832A2 (en) 2010-05-13 2011-11-17 Whitehead Institute For Biomedical Research Stem cells derived under low oxygen conditions
US9267123B2 (en) * 2011-01-05 2016-02-23 Sangamo Biosciences, Inc. Methods and compositions for gene correction
WO2012112737A2 (en) 2011-02-16 2012-08-23 The Regents Of The University Of California Alzheimer's disease cellular model for diagnostic and therapeutic development
GB201103631D0 (en) 2011-03-03 2011-04-13 Univ Leeds Identification of candidate therapeutics
US20130045483A1 (en) 2011-07-01 2013-02-21 Whitehead Institute For Biomedical Research Yeast cells expressing amyloid beta and uses therefor

Also Published As

Publication number Publication date
US20170153226A9 (en) 2017-06-01
IL241310A0 (en) 2015-11-30
HK1220232A1 (zh) 2017-04-28
CA2906197A1 (en) 2014-09-18
EP2971056A4 (en) 2016-11-23
WO2014145975A2 (en) 2014-09-18
US11047848B2 (en) 2021-06-29
JP7182852B2 (ja) 2022-12-05
WO2014145975A3 (en) 2014-12-31
BR112015023533A2 (pt) 2017-10-24
JP2020103289A (ja) 2020-07-09
EP2971056A2 (en) 2016-01-20
EP3736343A1 (en) 2020-11-11
IL241310B (en) 2021-12-01
CN105247070A (zh) 2016-01-13
JP2016513475A (ja) 2016-05-16
US20160041149A1 (en) 2016-02-11

Similar Documents

Publication Publication Date Title
HK1220233A1 (zh) 用於神經變性疾病的細胞性發現平台
HK1217215A1 (zh) 用於改變細胞表型的信號傳感器多核苷酸
HK1223158A1 (zh) 移動成像平台校準
SG11201604614UA (en) Modular mobile inspection vehicle
HK1214627A1 (zh) 大鼠的遺傳修飾
ZA201600708B (en) Mobile operating system
GB201322602D0 (en) Pharmaceutical compounds
GB201306610D0 (en) Pharmaceutical compounds
GB2515459B (en) Duplexers
GB201320799D0 (en) Mobile WiFi
ZA201602047B (en) Pharmaceutical compounds
EP2987923A4 (en) MOBILE COVERAGE
PL2853150T3 (pl) Mobilne urządzenie do przycinania drzew
GB201312386D0 (en) Pharmaceutical compounds
SMT201800400T1 (it) Composti pirazolopirimidinici
EP2989598A4 (en) SYSTEM FOR MOBILE BOOKINGS
SI2848467T1 (sl) Premičen oder
EP3027444B8 (en) Mobile accommodation
GB2518652B (en) Wireless geometry discovery
GB2518651B (en) Wireless geometry discovery
GB201302219D0 (en) Contraceptive compounds
AP00579S1 (en) Footsteps for vehicles
AP00577S1 (en) Footsteps for vehicles
AP00578S1 (en) Footsteps for vehicles
AP00580S1 (en) Footsteps for vehicles